Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FKBP5 | Q13451 | 1/20 | 0.35 |
| ▸ | DAO | P14920 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | AURKA | O14965 | 1/20 | 0.31 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.31 |
| ▸ | INCENP | Q9NQS7 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | HMBS | P08397 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrrole SCHEMBL27763221 | 0.97 | FKBP5 (0.33) | FKBP5DAOHDAC8HDAC6AURKA | |
| SCHEMBL47202 | 0.89 | — | — | |
| Phosphine SCHEMBL27520992 | 0.86 | — | — | |
| SCHEMBL28875380 | 0.86 | — | — | |
| SCHEMBL27763245 | 0.86 | — | — | |
| SCHEMBL29278232 | 0.86 | — | — | |
| Bromide SCHEMBL15820960 | 0.86 | — | — | |
| Hydrogen Sulfide SCHEMBL29094906 | 0.86 | — | — | |
| SCHEMBL27869458 | 0.86 | — | — | |
| Ammonia Solution, Strong SCHEMBL27712725 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111187271-B | Porphyrin organic small molecule receptor material, preparation method thereof and application thereof in organic solar cell | 华南理工大学 | 2021-05-14 | — | — | CN | claimed |
| CN-111187271-A | Porphyrin organic small molecule receptor material, preparation method thereof and application thereof in organic solar cell | 华南理工大学 | 2020-05-22 | — | — | CN | claimed |
| US-20080281091-A1 | Process for the Preparation of Porphyrin Derivatives as Antimicrobial Agents by Photodynamic Therapy (Pdt) | BRUNDISH DEREK | 2008-11-13 | — | — | US | claimed |
| EP-1963333-A1 | PROCESS FOR THE PREPARATION OF PORPHYRIN DERIVATIVES AS ANTIMICROBIAL AGENTS BY PHOTODYNAMIC THERAPY (PDT) | Destiny Pharma Limited (GB) | 2008-09-03 | — | — | EP | claimed |
| WO-2007074340-A1 | PROCESS FOR THE PREPARATION OF PORPHYRIN DERIVATIVES AS ANTIMICROBIAL AGENTS BY PHOTODYNAMIC THERAPY (PDT) | DESTINY PHARMA LIMITED (GB) | 2007-07-05 | — | — | WO | claimed |
| US-20050020560-A1 | Chlorins processing fused ring systems useful as photoselective compounds for photodynamic therapy | MIRAVANT PHARMACEUTICALS, INC. | 2005-01-27 | — | — | US | claimed |
| WO-2001074818-A1 | CHLORINS WITH FUSED RINGS FOR USE IN PHOTODYNAMIC THERAPY | MIRAVANT PHARMACEUTICALS, INC. (US) | 2001-10-11 | — | — | WO | claimed |
| US-5876864-A | Fluorene-based alternating polymers containing acetylene group and electroluminescence element using the same | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY | 1999-03-02 | — | — | US | claimed |
| WO-2024119026-A1 | BORON-CONTAINING CYCLIC EMISSIVE COMPOUNDS AND COLOR CONVERSION FILM CONTAINING THE SAME | NITTO DENKO CORPORATION (JP) | 2024-06-06 | — | — | WO | disclosed |
| WO-2023158977-A1 | BORON-CONTAINING CYCLIC EMISSIVE COMPOUNDS AND COLOR CONVERSION FILM CONTAINING THE SAME | NITTO DENKO CORPORATION (JP) | 2023-08-24 | — | — | WO | disclosed |
| WO-2023158976-A1 | BORON-CONTAINING CYCLIC EMISSIVE COMPOUNDS AND COLOR CONVERSION FILM CONTAINING THE SAME | NITTO DENKO CORPORATION (JP) | 2023-08-24 | — | — | WO | disclosed |
| WO-2022178427-A9 | BORON-CONTAINING CYCLIC EMISSIVE COMPOUNDS AND COLOR CONVERSION FILM CONTAINING THE SAME | NITTO DENKO CORPORATION (JP) | 2023-07-27 | — | — | WO | disclosed |
| US-20230051807-A1 | PORPHYRIN PHOTOSENSITIZER AND COBALOXIME COCATALYST AND METHODS OF USE THEREOF | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2023-02-16 | — | — | US | disclosed |
| WO-2022178427-A1 | BORON-CONTAINING CYCLIC EMISSIVE COMPOUNDS AND COLOR CONVERSION FILM CONTAINING THE SAME | NITTO DENKO CORPORATION (JP) | 2022-08-25 | — | — | WO | disclosed |
| WO-2003016330-A2 | MOLECULAR LINKERS SUITABLE FOR CRYSTALLIZATION AND STRUCTURAL ANALYSIS OF MOLECULES OF INTEREST, METHOD OF USING SAME, AND METHODS OF PURIFYING G PROTEIN-COUPLED RECEPTORS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2003-02-27 | — | — | WO | disclosed |
| WO-2000053580-A2 | N-PROTECTED SYNTHESIS METHOD FOR USE IN MAKING PORPHYRINS | EMORY UNIVERSITY (US) | 2000-09-14 | — | — | WO | disclosed |
| US-5876864-A | Fluorene-based alternating polymers containing acetylene group and electroluminescence element using the same | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY | 1999-03-02 | — | — | US | disclosed |
| US-5807974-A | POLYARYLENEVINYLENE RESIN | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 1998-09-15 | — | — | US | disclosed |
| US-5750816-A | USING CHROMIUM-BASED CATALYST SYSTEM COMPRISING A CHROMIUM COMPOUND, A NITROGEN-CONTAINING COMPOUND, AND AN ALKYLALUMINUM COMPOUND | MITSUBISHI CHEMICAL CORPORATION (JP) | 1998-05-12 | — | — | US | disclosed |
| US-4977117-A | Reacting oxides of nickel and molybdenum with a polysulfide, in first stage without hydrogen and in second stage without hydrogen; arcylamine present | EUROPEENNE DE RETRAITEMENT DE CATALYSEURS (FR) | 1990-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230051807-A1 | PORPHYRIN PHOTOSENSITIZER AND COBALOXIME COCATALYST AND METHODS OF USE THEREOF | PPOX, HMBS, PNPO | FKBP5 185/4885DAO 598/4885HDAC8 3525/4885 |
| US-20050020560-A1 | Chlorins processing fused ring systems useful as photoselective compounds for photodynamic therapy | PPOX, HMBS, DDT | FKBP5 1959/4885DAO 572/4885HDAC8 4563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.